News

The FTSE 100 sits at a record high. But some stocks still look dirt cheap!
The usually sluggish FTSE 100 is having a surprisingly good year. But our writer feels there are still potential bargains ...
Pharmabiz13h
GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk
GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk: London, UK Wednesday, July 16, 2025, 14:00 Hrs [IST] GSK ...